Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients
Status:
Terminated
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, placebo-controlled, parallel groups study to determine whether
prosptide is effective in relieving pain in patients who have sensory neuropathic pain
related to their HIV infection or the drugs used to treat it.